Primary Site >> Stomach Cancer
Gene >> ERCC2
| 1. | |||||||||||
| Journal: | World J Gastroenterol. 2006 Oct 7;12(37):6032-6. | ||||||||||
| Title: | Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy. | ||||||||||
| Author: | Zarate, R N|Arias, F|Bandres, E|Cubedo, E|Malumbres, R|Garcia-Foncillas, J | ||||||||||
| PMID: | 17009404 | ||||||||||
| 2. | |||||||||||
| Journal: | J Surg Oncol. 2010 Oct 1;102(5):454-61. | ||||||||||
| Title: | Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray. | ||||||||||
| Author: | Park, Chan-Hee|Rha, Sun-Young|Jeung, Hei-Cheul|Kang, Seung-Hui|Ki, Dong-Hyuk|Lee, Won-Suk|Noh, Sung-Hoon|Chung, Hyun-Cheol | ||||||||||
| PMID: | 20872948 | ||||||||||
| 3. | |||||||||||
| Journal: | PLoS One. 2012;7(9):e43431. | ||||||||||
| Title: | The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. | ||||||||||
| Author: | Xue, Huiping|Lu, Yan|Lin, Bing|Chen, Jinxian|Tang, Feng|Huang, Gang | ||||||||||
| PMID: | 23028453 | ||||||||||
| 4. | |||||||||||
| Journal: | Asian Pac J Cancer Prev. 2013;14(1):231-6. | ||||||||||
| Title: | XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies. | ||||||||||
| Author: | Yin, Qing-Hua|Liu, Chuan|Hu, Jian-Bing|Meng, Rong-Rong|Li, Lian|Wang, Ya-Jie | ||||||||||
| PMID: | 23534729 | ||||||||||
| 5. | |||||||||||
| Journal: | Mutagenesis. 2013 Jul;28(4):441-6. | ||||||||||
| Title: | A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. | ||||||||||
| Author: | Chu, Haiyan|Gu, Dongying|Xu, Ming|Xu, Zhi|Gong, Yonglin|Gong, Weida|Tang, Yongfei|Zhou, Jianwei|Tong, Na|Zhang, Zhengdong|Chen, Jinfei|Wang, Meilin | ||||||||||
| PMID: | 23680703 | ||||||||||
| 6. | |||||||||||
| Journal: | PLoS One. 2013 Sep 2;8(9):e71994. | ||||||||||
| Title: | ERCC1 and ERCC2 variants predict survival in gastric cancer patients. | ||||||||||
| Author: | Li, Yangkai|Liu, Zhensheng|Liu, Hongliang|Wang, Li-E|Tan, Dongfeng|Ajani, Jaffer A|Wei, Qing-Yi | ||||||||||
| PMID: | 24023723 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncol Lett. 2015 Oct;10(4):1997-2002. | ||||||||||
| Title: | Genetic variability of DNA repair mechanisms influences treatment outcome of gastric cancer. | ||||||||||
| Author: | Ding, Changmao|Zhang, Huiyu|Chen, Kuisheng|Zhao, Chunlin|Gao, Jianbo | ||||||||||
| PMID: | 26622786 | ||||||||||
| 8. | |||||||||||
| Journal: | Int J Clin Exp Pathol. 2015 Nov 1;8(11):15065-71. eCollection 2015. | ||||||||||
| Title: | Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy. | ||||||||||
| Author: | Mo, Juanmei|Luo, Min|Cui, Jiandong|Zhou, Shaozhang | ||||||||||
| PMID: | 26823845 | ||||||||||
| 9. | |||||||||||
| Journal: | Genet Mol Res. 2015 Dec 21;14(4):17529-35. | ||||||||||
| Title: | Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer. | ||||||||||
| Author: | Yu, W H|Wang, Y X|Guo, J Q|Wang, Y L|Zheng, J S|Zhu, K X | ||||||||||
| PMID: | 26782397 | ||||||||||
| 10. | |||||||||||
| Journal: | Genet Mol Res. 2015 Dec 17;14(4):17228-34. | ||||||||||
| Title: | Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients. | ||||||||||
| Author: | Zhong, G|Li, H K|Shan, T|Zhang, N | ||||||||||
| PMID: | 26681216 | ||||||||||
| 11. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2015 Dec;76(6):1285-95. | ||||||||||
| Title: | Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction. | ||||||||||
| Author: | Deenen, Maarten J|Meulendijks, Didier|Boot, Henk|Legdeur, Marie-Cecile J C|Beijnen, Jos H|Schellens, Jan H M|Cats, Annemieke | ||||||||||
| PMID: | 26499900 | ||||||||||
| 12. | |||||||||||
| Journal: | Int J Clin Exp Pathol. 2015 May 1;8(5):5563-9. eCollection 2015. | ||||||||||
| Title: | Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer. | ||||||||||
| Author: | Xue, Ming-Hui|Li, Guang-Yan|Wu, Xin-Jun|Zhang, Chao-Xian|Zhang, Cai-Feng|Zhu, Kong-Xi | ||||||||||
| PMID: | 26191265 | ||||||||||
| 13. | |||||||||||
| Journal: | Int J Clin Exp Pathol. 2015 Apr 1;8(4):4106-12. eCollection 2015. | ||||||||||
| Title: | Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer. | ||||||||||
| Author: | Yu, Hai|Wu, Xinghua|Zhang, Yonggang|Jin, Zhihong|Li, Guoxin|Zhao, Haiping | ||||||||||
| PMID: | 26097599 | ||||||||||
| 14. | |||||||||||
| Journal: | Tumour Biol. 2015 Apr;36(4):3017-23. | ||||||||||
| Title: | Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer. | ||||||||||
| Author: | Zhou, Jing|Liu, Zhi-yue|Li, Cun-bao|Gao, Shang|Ding, Li-hong|Wu, Xin-lin|Wang, Zhao-yang | ||||||||||
| PMID: | 25542228 | ||||||||||
| 15. | |||||||||||
| Journal: | Tumour Biol. 2016 Feb;37(2):1753-62. | ||||||||||
| Title: | Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy. | ||||||||||
| Author: | Liu, Rujiao|Zhao, Xiaoying|Liu, Xin|Chen, Zhiyu|Qiu, Lixin|Geng, Ruixuan|Guo, Weijian|He, Guang|Yin, Jiliang|Li, Jin|Zhu, Xiaodong | ||||||||||
| PMID: | 26314858 | ||||||||||
| 16. | |||||||||||
| Journal: | Genet Mol Res. 2016 Apr 26;15(2). pii: gmr7384. | ||||||||||
| Title: | Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer. | ||||||||||
| Author: | Zheng, D L|Tang, G D|Chen, Y N|Zhang, T|Qin, M B | ||||||||||
| PMID: | 27173253 | ||||||||||
| 17. | |||||||||||
| Journal: | Oncotarget. 2016 Jul 26;7(30):48130-48142. | ||||||||||
| Title: | Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer. | ||||||||||
| Author: | Liu, Jingwei|Deng, Na|Xu, Qian|Sun, Liping|Tu, Huakang|Wang, Zhenning|Xing, Chengzhong|Yuan, Yuan | ||||||||||
| PMID: | 27340861 | ||||||||||
| 18. | |||||||||||
| Journal: | Pharmacogenomics J. 2017 Oct;17(5):441-451. | ||||||||||
| Title: | Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies. | ||||||||||
| Author: | Meulendijks, D|Rozeman, E A|Cats, A|Sikorska, K|Joerger, M|Deenen, M J|Beijnen, J H|Schellens, J H M | ||||||||||
| PMID: | 27995989 | ||||||||||
| 19. | |||||||||||
| Journal: | Oncotarget. 2017 Jul 18;8(29):48488-48506. | ||||||||||
| Title: | Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. | ||||||||||
| Author: | Xiao, Feifan|Pu, Jian|Wen, Qiongxian|Huang, Qin|Zhang, Qinle|Huang, Birong|Huang, Shanshan|Lan, Aihua|Zhang, Yuening|Li, Jiatong|Zhao, Dong|Shen, Jing|Wu, Huayu|He, Yan|Li, Hongtao|Yang, Xiaoli | ||||||||||
| PMID: | 28489582 | ||||||||||
| 20. | |||||||||||
| Journal: | Cancer Manag Res. 2018 Apr 12;10:765-774. | ||||||||||
| Title: | Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population. | ||||||||||
| Author: | He, Jing|Zhuo, Zhen-Jian|Zhang, Anqi|Zhu, Jinhong|Hua, Rui-Xi|Xue, Wen-Qiong|Zhang, Shao-Dan|Zhang, Jiang-Bo|Li, Xi-Zhao|Jia, Wei-Hua | ||||||||||
| PMID: | 29695933 | ||||||||||